Advertisement

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome
Posted: 03/27/2024 | By: Sarah Campen, PharmD

Santhosh et al reported results of a single-site phase III randomized double-blind trial which assessed the efficacy of topical diclofenac in the prevention of capecitabine-induced hand-foot syndrome in the Journal of Clinical Oncology..

Question 1 of 5

Which statement about hand-foot syndrome is FALSE?

Choose 1

A
As many as 75% of patients receiving capecitabine develop hand-foot syndrome
B
The clinical term for hand-foot syndrome is palmar-plantar erythrodysesthesia
C
Severe hand-foot syndrome is often life-threatening
D
Hand-foot syndrome is associated with decreased quality of life

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage